Vaginal Atrophy – Pipeline Review, H1 2012

Global Markets Direct
March 19, 2012
55 Pages - SKU: GMD3811107
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update
7/7/2014 | published by: GlobalData
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky mucus which clogs the lungs and leads to  |  read more...
USD 5,995
Proteins in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Proteins in Oncology Drug Pipeline Update 2014 This drug pipeline update covers proteins, excluding antibodies, as drugs for the treatment of cancer. There are today 326 companies plus partners developing 359 protein drugs in 667 developmental projects  |  read more...
USD 6,746
Follicular Lymphoma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Follicular Lymphoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Follicular  |  read more...
USD 2,000
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014’, provides an overview of the Peripheral Arterial  |  read more...
USD 2,000
Malignant Mesothelioma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Malignant Mesothelioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant  |  read more...
USD 2,000
Myocardial Infarction - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Myocardial Infarction - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H2 2014’, provides an overview of the Myocardial Infarction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myocardial  |  read more...
USD 2,000
Bone Marrow Transplantation - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Bone Marrow Transplantation - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Bone Marrow Transplantation - Pipeline Review, H2 2014’, provides an overview of the Bone Marrow Transplantation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014’, provides an overview of the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)’s therapeutic pipeline. This report  |  read more...
USD 2,000
Batten Disease - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Batten Disease - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Batten Disease - Pipeline Review, H2 2014’, provides an overview of the Batten Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Batten  |  read more...
USD 2,000
Cirrhosis - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Cirrhosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cirrhosis - Pipeline Review, H2 2014’, provides an overview of the Cirrhosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cirrhosis, complete with comparative  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 500  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!